Results for tag: "Demecarium Bromide"

Demecarium bromide is a chemical compound used in the treatment of glaucoma, a condition that causes increased pressure in the eye. It is a cholinesterase inhibitor, meaning it works by blocking the breakdown of acetylcholine, a neurotransmitter that helps regulate eye pressure. Demecarium bromide is available in both oral and topical forms, and is typically prescribed in combination with other medications. The market for demecarium bromide is largely driven by the prevalence of glaucoma, which is estimated to affect over 60 million people worldwide. The market is also driven by the increasing demand for more effective treatments for glaucoma, as well as the development of new formulations of demecarium bromide. Some of the major companies in the demecarium bromide market include Allergan, Bausch + Lomb, Merck, Novartis, Pfizer, and Santen Pharmaceuticals. Show Less Read more